GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shilpa Medicare Ltd (BOM:530549) » Definitions » Deferred Policy Acquisition Costs

Shilpa Medicare (BOM:530549) Deferred Policy Acquisition Costs


View and export this data going back to 1995. Start your Free Trial

What is Shilpa Medicare Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Shilpa Medicare Business Description

Traded in Other Exchanges
Address
Hyderabad Road, Number 12-6-214/A-1, Shilpa House, Raichur, KA, IND, 584135
Shilpa Medicare Ltd is a specialty and generic drug manufacturer. The company's product range includes over 44 oncology and non-oncology APIs. It uses nano and micro technology in its drug identification and formulation. The operating segments of the company are Pharmaceutical products and services, which is the key revenue-generating segment; and Power sales. Geographically, the group derives revenue from India and Outside India, of which prime revenue is generated from India.